NFE2L2 and type 2 diabetes mellitus: Although estrogens are widely recognized to exert antioxidant and regulatory functions on the immune system and the expression of cytokines, whether these hormones alter the inflammatory response or the antioxidant regulatory enzymes (Nrf2 and phase II enzymes) observed in animal models of insulin resistance and type 2 diabetes has not been addressed to date.